Ryan Lynch, See Remarks at CRESCENT BIOPHARMA, INC. (CBIO), sold 465 shares at $17.99 ($8K) on 2026-06-22, disclosed to the SEC on 2026-06-23.
Scheduled sale ($8k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |